Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Key International (BKYI) Income from Continuing Operations (2016 - 2025)

Bio Key International's Income from Continuing Operations history spans 16 years, with the latest figure at 964849.0 for Q3 2025.

  • For Q3 2025, Income from Continuing Operations fell 30.57% year-over-year to 964849.0; the TTM value through Sep 2025 reached 4253287.0, up 19.58%, while the annual FY2024 figure was 4300692.0, 49.53% up from the prior year.
  • Income from Continuing Operations for Q3 2025 was 964849.0 at Bio Key International, up from 1167396.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 48336.0 in Q2 2021 and bottomed at 4982554.0 in Q4 2022.
  • The 5-year median for Income from Continuing Operations is 1384497.0 (2024), against an average of 1562482.95.
  • The largest annual shift saw Income from Continuing Operations surged 93.49% in 2021 before it plummeted 3456.27% in 2022.
  • A 5-year view of Income from Continuing Operations shows it stood at 2017020.0 in 2021, then plummeted by 147.03% to 4982554.0 in 2022, then soared by 52.38% to 2372814.0 in 2023, then soared by 41.65% to 1384497.0 in 2024, then skyrocketed by 30.31% to 964849.0 in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Income from Continuing Operations are 964849.0 (Q3 2025), 1167396.0 (Q2 2025), and 736545.0 (Q1 2025).